Home

Athyrium Opportunities III Acquisition 2 LP

CIK 1815268 · last filed 2024-07-08

Athyrium Opportunities III Acquisition 2 LP is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing, for BIOR, was dated Jul 8, 2024. The firm reports its address in New York, NY. 13 SEC filings were submitted jointly with Athyrium Opportunities 2020 LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

1

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
505 FIFTH AVENUE, FLOOR 18
NEW YORK, NY 10017
Phone
(646) 434-1636
State of Incorporation
DE
Related Filers
Athyrium Opportunities 2020 LP — 13 joint filings, latest 2024-12-16
Athyrium Opportunities Associates III GP LLC — 13 joint filings, latest 2024-12-16
Athyrium Funds GP Holdings LLC — 8 joint filings, latest 2024-12-16
Athyrium Opportunities III Acquisition LP — 8 joint filings, latest 2024-12-16
Jeffrey Ferrell — 8 joint filings, latest 2024-12-16
Athyrium Opportunities Associates GP LLC — 5 joint filings, latest 2021-06-14
Athyrium Opportunities Associates LP — 5 joint filings, latest 2021-06-14
Athyrium Opportunities Fund (A) LP — 5 joint filings, latest 2021-06-14
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BIORA THERAPEUTICS, INC. (BIOR) Delisted Director — $0.22 — $0 1 2024-07-08

Recent Filings

1 filing
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-07-08 BIORA THERAPEUTICS, INC. (BIOR) Delisted Grant (A) — $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.